论文部分内容阅读
作者用合併或不合併化疗的高能放射疗法对105例鼻咽癌病人进行了治疗,并作了回顾性调查。接受治疗的这组病人中,男性77例,女性28例,年龄15～80岁(平均53岁);Ⅰ期4人,Ⅱ期6人,Ⅲ期24人,Ⅳ期71人,病理学资料:鳞癌92例,囊腺癌2例、粘液表皮样癌1例,淋巴上皮癌1例,未分化癌4例,移行细胞癌5例。病人在此之前未接受过治疗,且鼻咽部活检阳性。治疗时,放射源用~(60+)钴或4-10MV的直线加速器,原发灶放射剂量一般为50Gy/25次/35天至80Gy/42次/66天;对于颈部淋巴结受累者,其颈部亦给予放射治疗;少数
The authors treated 105 patients with nasopharyngeal carcinoma with high-energy radiation therapy, with or without chemotherapy, and were retrospectively reviewed. Among the patients treated, 77 were males and 28 were females, aged from 15 to 80 years old (mean 53 years); stage Ⅰ 4, stage Ⅱ 6, stage Ⅲ 24, stage Ⅳ 71, pathological data 92 cases of squamous cell carcinoma, 2 cases of cystadenocarcinoma, 1 case of mucoepidermoid carcinoma, 1 case of lymphoepithelial carcinoma, 4 cases of undifferentiated carcinoma and 5 cases of transitional cell carcinoma. The patient had not been previously treated and the nasopharynx biopsy was positive. Treatment, the radioactive sources with ~ (60 +) cobalt or 4-10MV linear accelerator, the primary tumor radio dose is generally 50Gy / 25 times / 35 days to 80Gy / 42 times / 66 days; for cervical lymph node involvement, The neck is also given radiotherapy; a few